| ACD | Allergic contact dermatitis |
| AD | Atopic dermatitis |
| APC | Antigen presenting cell |
| AT | Adipose tissue |
| BM | Bone marrow |
| Breg | Regulatory B lymphocyte |
| CD | Clusters of differentiation |
| CHS | Contact hypersensitivity |
| CLE | Cutaneous lupus erythematosus |
| COX-2 | Cyclooxygenase 2 |
| CTL | Cytotoxic T lymphocyte |
| DC | Dendritic cell |
| Df | Dermatophagoides farinae |
| DTH | Delayed type hypersensitivity |
| EASI | Eczema Area and Severity Index |
| FcεRI | High affinity immunoglobulin E receptor |
| GvHD | Graft-versus-host disease |
| HClO | Hypochlorous acid |
| HGF | Hepatocyte growth factor |
| HLA | Human leukocyte antigen |
| ICD | Irritant contact dermatitis |
| IDO | Indoleamine 2,3-dioxygenase |
| IFN | Interferon |
| Ig | Immunoglobulin |
| IL | Interleukin |
| IV | Intravenous or intravenously |
| IMQ | Imiquimod |
| LPS | Lipopolysaccharide |
| MC | Mast cell |
| MHC | Major histocompatibility complex |
| MSC | Mesenchymal stem cell |
| NK | Natural killer |
| NO | Nitric oxide |
| OVA | Ovalbumin |
| PASI | Psoriasis Area and Severity Index |
| PGE2 | Prostaglandin E2 |
| SC | Subcutaneous or subcutaneously |
| SLE | Systemic lupus erythematosus |
| SSc | Systemic sclerosis |
| TGF | Transforming growth factor |
| Th | T helper lymphocyte |
| TLR | Toll-like receptor |
| TNF | Tumor necrosis factor |
| Treg | Regulatory T lymphocyte |
| UC | Umbilical cord |
| UCB | Umbilical cord blood |